The project work of the Global Pharma Health Fund (GPHF) is currently focussing on the GPHF-Minilab® for rapid drug quality verification and easy counterfeit medicines detection.
The GPHF-Minilab® is a mobile mini-laboratory that allows quick, reliable testing of 63 active ingredients, showing whether or not the right drug in the right quantity is present in the appropriate single and fixed-dose combination products. The toolbox has been specifically designed for use in developing countries that are heavily affected by counterfeit medicines and are lacking the facilities for effective medicine testing.
The project work of the Global Pharma Health Fund fosters worldwide cooperation. Promoters and project partners are the World Health Organization (WHO) in Geneva and major NGOs from the US, for example Management Sciences for Health (MSH) and the Promoting the Quality of Medicines programme of the United States Pharmacopeia (USP PQM).
Support comes also from the German Agency for International Cooperation (GIZ) and faith-based organisations, for example, from the Medical Mission Institute Würzburg, the medicines relief organisation action medeor and the German Doctors for Developing Countries.
The project is managed by Dr. Richard W. O. Jähnke, a qualified manufacturing pharmacist with a master in business administration. He coordinates GPHF-Minilab® development and implementation, and responses to information and training requests.